Thank you for donating!

You can donate using the following services.

Resources

We aim to provide up-to-date, comprehensive and practical information and advice for those affected by Niemann-Pick diseases as well as information and resources specifically for health, education and social care professionals. The information we develop covers a broad range of topics to enable you to tailor information for your needs. Please feel free to share any of the resources available. If you have any questions or need further information then please contact us at any time.

Resources

Support us

Latest news

25.08.16

CTD Holdings to Host Webinar to Provide Update on Trappsol® Cyclo™ Drug Development Program for Treatment of Niemann-Pick Disease Type C

CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease, today announced that it will host a webinar to provide details of the Company’s recently initiated Phase I clinical trial in the U.S. and Phase I/II clinical trial in the EU, both evaluating CTD’s proprietary formulation of hydroxypropyl beta cyclodextrin, Trappsol® Cyclo™, for the treatment of Niemann-Pick Disease Type C (NPC). NPC is a rare and fatal genetic disease that damages the brain, lung, liver, spleen, and other organs.

Read more

25.08.16

NPUK Annual Family Conference & Interactive Workshop 2017

We are looking forward to our next Annual Family Conference & Interactive Workshop, and we hope you are too! The event is the biggest in the NPUK calendar, and this year will be held 22nd-24th September 2017 at the Mercure Haydock Hotel, Merseyside, UK.

Read more
View all news Subscribe